Autoliv Renews €3 Billion EMTN Programme

Autoliv, Inc. has announced the renewal of its €3,000,000,000 guaranteed Euro Medium Term Note Programme (EMTN Programme) for one year, approved by the funding committee of the board of directors. The renewal will enable the company to leverage funding opportunities in the capital markets and from institutional investors through the issuance of notes.

The base listing particulars for the renewed EMTN Programme, dated March 6, 2024, have been approved by Euronext Dublin and are available for viewing on its website. In 2023, Autoliv's products saved 35,000 lives and reduced over 450,000 injuries, with sales amounting to US $10.5 billion.

Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.